Forty years of human G‐ CSF : A short history in time
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19713 ↗Kurz gefasst
Historischer Beitrag in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Karl Welte. Beteiligte Einrichtung: University Children's Hospital, Tuebingen, Germany. Hauptthemen laut MEDLINE: Granulocyte Colony-Stimulating Factor, Neutropenia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Human G‐CSF was identified in 1984 at Memorial Sloan‐Kettering Cancer Centre, New York. Based on these findings, recombinant G‐CSF was developed by Amgen, Thousand Oaks. In 1987, clinical trials began using recombinant G‐CSF in cancer patients following chemotherapy to reduce the duration of neutropenia and in patients with congenital neutropenia (CN) to increase the number of neutrophils. It has changed the quality of life for many cancer patients and saved the lives of many patients with (CN).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Children's Hospital, Tuebingen, Germany.
ORCID-Profile: Karl Welte
Zitieren
APA
Welte, K. (2024). Forty years of human G‐ CSF : A short history in time. British Journal of Haematology. https://doi.org/10.1111/bjh.19713
Vancouver
Welte K. Forty years of human G‐ CSF : A short history in time. British Journal of Haematology. 2024. doi:10.1111/bjh.19713
BibTeX
@article{Welte2024,
author = {Welte, Karl},
title = {Forty years of human G‐ CSF : A short history in time},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19713}
}
EUVIMED